New KRAS mutant inhibitors reported in Université de Montréal patent
Université de Montreal has identified new GTPase KRAS mutant inhibitors potentially useful for the treatment of cancer, inflammatory and immunological disorder.
BioDir |
BioDir Université de Montreal has identified new GTPase KRAS mutant inhibitors potentially useful for the treatment of cancer, inflammatory and immunological disorder.